Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.

24 Dec 2009

Tips to minimize injuries during winter season

As we try to get outside and make the most of these cold winter months, it's important to use basic safety tips that help minimize injury. The Minnesota Chiropractic Association (MCA) offers the following tips to help keep your family injury free.

24 Dec 2009

Forest Laboratories acquires additional rights to NXL 104 beta-lactamase inhibitor

Forest Laboratories announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds additional rights to the combination of ceftazidime and NXL 104, through a transaction with AstraZeneca executed immediately following AstraZeneca’s announced acquisition of Novexel, S.A.

24 Dec 2009

More H1N1 vaccines available in U.S., many Americans don't want it

While an increasing number of H1N1 (swine flu) vaccines are available in the U.S., "more than half of American adults say they still don't want it, and one-third of parents say they don't want their children to get it either, according to two surveys," the Washington Post reports. "As of this week, 111 million doses of vaccine against the pandemic strain of H1N1 flu have been released to states and cities.

24 Dec 2009

Fluzone High-Dose inactivated influenza virus vaccine receives FDA approval

The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

24 Dec 2009

AstraZeneca signs definitive agreement to acquire Novexel

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial drug resistance, announces today that its shareholders have signed a definitive agreement whereby Novexel shall be acquired by AstraZeneca for a total cash consideration of up to $505 million, including contingent payments and the net cash position of the company at closing.

24 Dec 2009

Elusys Therapeutics receives contract to speed up drug development for Anthrax

The HHS Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to Elusys Therapeutics, Inc. of Pine Brook, N.J., for the advanced development of a medication to treat inhalational anthrax, one of the top bioterrorism threats facing the nation.

23 Dec 2009

Majority of Australians think H1N1 vaccination is not necessary

Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.

23 Dec 2009

Gene's role in immune system may suggest new treatments for childhood asthma

Pediatric researchers have identified a novel gene involved in childhood asthma, in one of the largest gene studies to date of the common respiratory disease. Because the gene, called DENND1B, affects cells and signaling molecules thought to be instrumental in the immune system overreaction that occurs in asthma, the discovery may have singled out an important target for new treatments.

23 Dec 2009

Cold Spring Publishing renamed as Harborside Press

Cold Spring Publishing, LLC, announced today that the principals of the company have approved a name change to Harborside Press, LLC.

23 Dec 2009

Food safety leader organizes holiday recipe contest to highlight food borne illness

It's not too late! Enter the National Pasteurized Eggs, (www.SafeEggs.com), makers of Davidson's Safest Choice Pasteurized Shell Eggs, best holiday recipe contest. Designed by National Pasteurized Eggs, food safety leader, to celebrate the season and remind at-home chefs and bakers about food borne illness, the Davidson's Safest Choice "Safest Recipes" contest runs through Dec. 31, 2009.

23 Dec 2009

One-third of parents do not expect to get H1N1 vaccine for kids; concerns about safety remains major factor

A new poll by researchers at the Harvard School of Public Health (HSPH) shows the shortage of H1N1 vaccine for children is easing. As of late last week, three-quarters of parents who tried to get the vaccine for their children were able to do so.

23 Dec 2009

Older adults face higher risk of hospitalization for pneumonia when exposed to pollution

Older adults with long-term exposure to higher levels of pollution are at higher risk for hospitalization for pneumonia, according to researchers in Canada.

23 Dec 2009

New research shows accurate taste perception relies on properly functioning olfactory system

As anyone suffering through a head cold knows, food tastes wrong when the nose is clogged, an experience that leads many to conclude that the sense of taste operates normally only when the olfactory system is also in good working order.

23 Dec 2009

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.

23 Dec 2009

Brazilian researchers perform autopsy study to examine the causes H1N1 death

Brazilian researchers have performed the first-ever autopsy study to examine the precise causes of death in victims of the H1N1 swine flu.

23 Dec 2009

Hand sanitizers become popular promotional products

The Advertising Specialty Institute® announced that hand sanitizers now rival pens as the most popular logoed items that companies are giving away to clients and employees.

23 Dec 2009

Prolonged exposure to higher levels of pollutants can lead to hospitalization for pneumonia

A McMaster University researcher has found the first evidence that prolonged exposure to higher levels of the pollutants found in car exhaust fumes and industrial air pollution can lead to hospitalization for pneumonia in adults aged 65 and older.

23 Dec 2009

New community-associated strain of MRSA more apt to cause serious problems

The often feared and sometimes deadly infections caused by MRSA - methicillin-resistant Staphylococcus aureus - are now moving out of hospitals and emerging as an even more virulent strain in community settings and on athletic teams, and raising new concerns about antibiotic resistance.

23 Dec 2009

Macomb County Health Department announces 2009 H1N1 influenza vaccination program

The last large H1N1 influenza vaccination clinic for the 2009 flu season has been scheduled by the Macomb County Health Department. It is free of charge and will take place next Monday, Dec. 28, at Bethesda Christian Church in Sterling Heights from 10 a.m. to 3 p.m. Everyone over 6 months of age can receive the vaccine at this clinic.

23 Dec 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Tips to minimize injuries during winter season

Forest Laboratories acquires additional rights to NXL 104 beta-lactamase inhibitor

More H1N1 vaccines available in U.S., many Americans don't want it

Fluzone High-Dose inactivated influenza virus vaccine receives FDA approval

AstraZeneca signs definitive agreement to acquire Novexel

Elusys Therapeutics receives contract to speed up drug development for Anthrax

Majority of Australians think H1N1 vaccination is not necessary

Gene's role in immune system may suggest new treatments for childhood asthma

Cold Spring Publishing renamed as Harborside Press

Food safety leader organizes holiday recipe contest to highlight food borne illness

One-third of parents do not expect to get H1N1 vaccine for kids; concerns about safety remains major factor

Older adults face higher risk of hospitalization for pneumonia when exposed to pollution

New research shows accurate taste perception relies on properly functioning olfactory system

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

Brazilian researchers perform autopsy study to examine the causes H1N1 death

Hand sanitizers become popular promotional products

Prolonged exposure to higher levels of pollutants can lead to hospitalization for pneumonia

New community-associated strain of MRSA more apt to cause serious problems

Macomb County Health Department announces 2009 H1N1 influenza vaccination program

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in